વર્તમાન કિંમત
WuXi PharmaTech (Cayman) Inc. is a leading global contract research and manufacturing organization that provides comprehensive services for the pharmaceutical, biotechnology, and medical device industries. The company sp...|
e.g. Promoter holding
Loading chart...
વિશ્લેષક સર્વસંમતિ EPS અને આવક અનુમાન.
આ કંપની માટે કમાણી અંદાજ ઉપલબ્ધ નથી.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AACCOM INC | ACMM | — | — | — | — | — | — | — |
| 2. | AActions Se... | ACTS | — | — | — | — | — | — | — |
| 3. | AAegon Fund... | AEFC | — | — | — | — | — | — | — |
| 4. | AFederal Ag... | AGM-P-D | — | — | — | — | — | — | — |
| 5. | AArmada Hof... | AHH-P-A | — | — | — | — | — | — | — |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Quarter (M) | Dec 13 | Mar 14 | Jun 14 | Sep 14 | Dec 14 | Mar 15 | Jun 15 | Sep 15 |
|---|---|---|---|---|---|---|---|---|
Revenue | 157.17 | 146.72 | 163.35 | 173.56 | 190.65 | 180.04 | 194.14 | 213.64 |
COGS | 97.5 | 93.09 | 101.82 | 107.37 | 120.26 | 117.23 | 127.44 | 137.75 |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 33.55 | 34.59 | 38.37 | 44.16 | 52.11 | 52.19 | 57.33 | 57.09 | |
EBIT | 29.36 | 23.41 | 28 | 27.75 | 24.56 | 16.99 | 17.05 | 25.82 |
OPM % | 18.68% | 15.96% | 17.14% | 15.99% | 12.88% | 9.44% | 8.78% | 12.09% |
Non-Operating Income | 11.37 | -1.72 | 8.01 | 11.51 | 15.09 | 5.04 | 5.82 | -5.3 |
PBT | 40.74 | 21.69 | 36.01 | 39.26 | 39.65 | 22.03 | 22.87 | 20.52 |
Income Tax | 7.88 | 3.87 | 6.67 | 7.26 | 6.65 | 4.25 | 3.42 | 4.45 |
Tax Rate % | 19.35% | 17.84% | 18.53% | 18.49% | 16.78% | 19.27% | 14.96% | 21.7% |
Net Income | 32.86 | 17.82 | 29.34 | 32 | 33 | 17.79 | 18.87 | 15.1 |
NPM % | 20.9% | 12.15% | 17.96% | 18.44% | 17.31% | 9.88% | 9.72% | 7.07% |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 33.78 | 69.94 | 135.21 | 253.49 | 270.02 | 334.06 | 407.18 | 499.91 | 578.08 | 674.28 |
COGS | 13.47 | 31.77 | 63.4 | 126.11 | 137.64 | 174.15 | 216.74 | 275 | 321.78 | 376.18 |
Gross Profit | 20.31 | 38.17 | 71.81 | 127.38 | 132.38 | 159.91 | 190.44 | 224.91 | 256.31 | 298.1 |
Gross Profit % | 60.12% | 54.58% | 53.11% | 50.25% | 49.03% | 47.87% | 46.77% | 44.99% | 44.34% | 44.21% |
| 9.54 | 24.18 | 32.66 | 56.77 | 56.28 | 50.58 | 78.03 | 101.93 | 117.27 | 169.23 | |
EBIT | 8.74 | 10.13 | 30.2 | 39.57 | 52.13 | 80.12 | 83.81 | 89.44 | 105.24 | 103.73 |
OPM % | 25.87% | 14.48% | 22.33% | 15.61% | 19.31% | 23.98% | 20.58% | 17.89% | 18.21% | 15.38% |
Non-Operating Income | -1.54 | -0.88 | 5.21 | 0 | 6.83 | 20.93 | 13.78 | 14.53 | 32.79 | 32.88 |
PBT | 7.2 | 9.25 | 35.4 | 0 | 58.96 | 101.06 | 97.58 | 103.98 | 138.03 | 136.61 |
Income Tax | 1.07 | 0.4 | 1.5 | 0 | 5.53 | 10.24 | 16.61 | 17.39 | 23.46 | 24.45 |
Tax Rate % | 14.92% | 4.3% | 4.23% | - | 9.38% | 10.14% | 17.02% | 16.73% | 17% | 17.9% |
Net Income | 6.13 | 8.85 | 33.9 | 0 | 52.87 | 90.81 | 80.98 | 86.58 | 114.57 | 112.16 |
NPM % | 18.14% | 12.66% | 25.08% | - | 19.58% | 27.18% | 19.89% | 17.32% | 19.82% | 16.63% |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.87 | 9.68 | 213.59 | 56.63 | 80.51 | 115.4 | 71.37 | 54.13 | 88.87 | 211.46 | |
| 0.62 | 2.07 | 5.53 | 15.97 | 23.44 | 40.07 | 130.51 | 175.67 | 305.41 | 224.33 | |
| 22.83 | 42.78 | 73.64 | 152.7 | 181.83 | 205.55 | 245.69 | 264.38 | 279.25 | 351.69 | |
| 4.59 | 12.31 | 24.57 | 20.71 | 24.4 | 32.4 | 60.48 | 66.58 | 76.53 | 80.54 | |
| 7.97 | 18.85 | 26.46 | 90.39 | 97.12 | 104.71 | 156.09 | 181.77 | 198.8 | 313.62 | |
Total Assets | 40.87 | 85.69 | 343.77 | 336.4 | 407.3 | 498.13 | 664.14 | 742.53 | 948.87 | 1,181.63 |
| 4.98 | 4.62 | 9.85 | 10.59 | 11.01 | 11.22 | 11.41 | 11.22 | 11.45 | 11.22 | |
| 12.26 | 43.56 | 241.55 | 220.29 | 269.12 | 381.61 | 494.32 | 567 | 723.3 | 766.63 | |
| 5.04 | 5.76 | 45.09 | 38.17 | 37.98 | 37.72 | 1.65 | 5.7 | 11.12 | 13.99 | |
| 8.39 | 20.93 | 41.51 | 50.54 | 44.02 | 56.54 | 74 | 84.03 | 119.15 | 163.75 | |
| 10.19 | 10.82 | 5.77 | 16.82 | 45.17 | 11.05 | 82.78 | 74.59 | 83.85 | 226.03 | |
Total Liabilities | 40.87 | 85.69 | 343.77 | 336.4 | 407.3 | 498.13 | 664.14 | 742.53 | 948.87 | 1,181.63 |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.06 | 15.33 | 65.23 | 60.66 | 69.77 | 125.65 | 101.06 | 131.06 | 181.51 | 140.38 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3.58 | 15.54 | 180.49 | 0 | 27.98 | 0 | 29.77 | 0 | 17.93 | 38.14 | |
Net CFNet Cash Flow | 12.63 | 30.87 | 245.72 | 60.66 | 97.76 | 125.65 | 130.84 | 131.06 | 199.44 | 178.52 |
FCFFree Cash Flow | 0.65 | -9 | 25.13 | -2.59 | 14.78 | 76.78 | 37.66 | 64.19 | 128.08 | 42.25 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 27.1% | 22.6% | - | 20.7% | 27.0% | 18.0% | 16.0% | 17.5% | 14.8% | |
| 0.29 | 0.12 | 0.18 | 0.17 | 0.14 | 0.10 | 0.00 | 0.01 | 0.02 | 0.02 | |
| - | - | - | - | - | - | - | - | - | - | |
| - | 1.11 | 0.63 | 0.75 | 0.73 | 0.74 | 0.70 | 0.71 | 0.68 | 0.63 | |
Cash Conversion | 1.48 | 1.73 | 1.92 | - | 1.32 | 1.38 | 1.25 | 1.51 | 1.58 | 1.25 |
Payout Ratio | 27.5% | 76.2% | - | - | - | - | - | - | - | - |
| - | 107.0% | 93.3% | 87.5% | 6.5% | 23.7% | 21.9% | 22.8% | 15.6% | 16.6% | |
| - | - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | - | |
| 4.00 | 5.00 | 3.00 | 3.00 | 4.00 | 6.00 | 4.00 | 5.00 | 4.00 | 4.00 | |
| - | -1.72 | -1.66 | -2.71 | -2.57 | -2.42 | -2.44 | -2.51 | -2.62 | -2.63 | |
| 100.00 | 95.00 | 90.00 | 100.00 | 90.00 | 95.00 | 90.00 | 85.00 | 90.00 | 85.00 | |
| 0.2% | 0.1% | 0.3% | - | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
WuXi PharmaTech Cayman Inc. ADR ની માલિકી કોની પાસે છે, SEC ફાઇલિંગ્સ મુજબ
Shares sold short · updated twice a month
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 456 | +1202.9% | 3.48 | |
| 15 Oct 2026 | 35 | -87.1% | 1.00 | |
| 30 Sep 2026 | 271 | -13.7% | 1.00 | |
| 15 Sep 2026 | 314 | +188.1% | 1.93 | |
| 31 Aug 2026 | 109 | +28.2% | 1.00 | |
| 14 Aug 2026 | 85 | +54.5% | 1.47 | |
| 31 Jul 2026 | 55 | +111.5% | 1.17 | |
| 15 Jul 2026 | 26 | +85.7% | 1.86 | |
| 30 Jun 2026 | 14 | -58.8% | 1.00 | |
| 15 Jun 2026 | 34 | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
WuXi PharmaTech Cayman Inc. ADR ના SEC ફાઇલિંગ્સ અને અર્નિંગ્સ કૉલ ટ્રાન્સક્રિપ્ટ્સ
What recent news says about WuXi PharmaTech Cayman Inc. ADR, scored for sentiment.